Phibro Animal Health Corp. (PAHC)
35.36
-0.96
(-2.64%)
USD |
NASDAQ |
Aug 24, 16:00
35.36
0.00 (0.00%)
After-Hours: 20:00
Phibro Animal Health Enterprise Value : 2.183B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 2.183B |
| August 20, 2026 | 2.137B |
| August 19, 2026 | 2.148B |
| August 18, 2026 | 2.116B |
| August 17, 2026 | 2.115B |
| August 14, 2026 | 2.104B |
| August 13, 2026 | 2.092B |
| August 12, 2026 | 2.081B |
| August 11, 2026 | 2.092B |
| August 10, 2026 | 2.095B |
| August 07, 2026 | 2.101B |
| August 06, 2026 | 2.150B |
| August 05, 2026 | 2.171B |
| August 04, 2026 | 2.194B |
| August 03, 2026 | 2.217B |
| July 31, 2026 | 2.184B |
| July 30, 2026 | 2.189B |
| July 29, 2026 | 2.209B |
| July 28, 2026 | 2.185B |
| July 27, 2026 | 2.139B |
| July 24, 2026 | 2.091B |
| July 23, 2026 | 2.091B |
| July 22, 2026 | 2.081B |
| July 21, 2026 | 2.084B |
| July 20, 2026 | 2.051B |
| Date | Value |
|---|---|
| July 17, 2026 | 2.061B |
| July 16, 2026 | 2.110B |
| July 15, 2026 | 2.079B |
| July 14, 2026 | 2.050B |
| July 13, 2026 | 2.049B |
| July 10, 2026 | 2.011B |
| July 09, 2026 | 2.023B |
| July 08, 2026 | 2.026B |
| July 07, 2026 | 2.053B |
| July 06, 2026 | 2.094B |
| July 02, 2026 | 2.059B |
| July 01, 2026 | 2.012B |
| June 30, 2026 | 1.984B |
| June 29, 2026 | 2.000B |
| June 26, 2026 | 1.995B |
| June 25, 2026 | 2.001B |
| June 24, 2026 | 1.982B |
| June 23, 2026 | 1.948B |
| June 22, 2026 | 1.970B |
| June 18, 2026 | 2.002B |
| June 17, 2026 | 1.961B |
| June 16, 2026 | 2.003B |
| June 15, 2026 | 2.019B |
| June 12, 2026 | 1.989B |
| June 11, 2026 | 1.978B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Zoetis, Inc. | 39.75B |
| Merck & Co., Inc. | 423.37B |
| ANI Pharmaceuticals, Inc. | 1.966B |
| Corcept Therapeutics, Inc. | 12.89B |
| Veru, Inc. | 21.90M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 24.02M |
| Revenue (Quarterly) | 383.54M |
| Total Expenses (Quarterly) | 359.52M |
| EPS Diluted (Quarterly) | 0.5854 |
| Gross Profit Margin (Quarterly) | 32.56% |
| Profit Margin (Quarterly) | 6.26% |
| Earnings Yield | 6.58% |
| Operating Earnings Yield | 12.71% |
| Normalized Earnings Yield | 7.103 |